[{"AccountsPayableCurrent_0_Q1_USD":3078000.0,"ConvertibleDebtNoncurrent_0_Q1_USD":144561000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-230000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":418897000.0,"RestrictedCashCurrent_0_Q1_USD":1016000.0,"OtherAssetsCurrent_0_Q1_USD":1891000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":671000.0,"PaymentsToAcquireAvailableForSaleSecurities_1_Q1_USD":227419000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":1394000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":1674000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":1164000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":1164000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-167658000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":7002000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-9991000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":381458000.0,"OtherAssetsNoncurrent_0_Q1_USD":845000.0,"MarketableSecuritiesCurrent_0_Q1_USD":228813000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":9294000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":66912000.0,"DerivativeGainLossOnDerivativeNet_1_Q1_USD":-68406000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0832,"OperatingLeaseRightOfUseAsset_0_Q1_USD":13715000.0,"OperatingLeasePayments_1_Q1_USD":968000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":11396000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2732000.0,"OperatingLeaseLiability_0_Q1_USD":14128000.0,"OperatingLeaseCost_1_Q1_USD":1000000.0,"LongTermPurchaseCommitmentAmount_1_Q1_USD":22600000.0,"CurrentIncomeTaxExpenseBenefit_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":2951000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":3518000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":3283000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":3288000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":4107000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":17079000.0,"InvestmentIncomeNonoperating_1_Q1_USD":2275000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":460000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-152000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":2883000.0,"PrepaidExpenseCurrent_0_Q1_USD":22806000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":14000.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":3004000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-227854000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":403267000.0,"LiabilitiesCurrent_0_Q1_USD":50740000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":688939000.0,"Liabilities_0_Q1_USD":429942000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-5237000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":29504000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-2.29,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-108349000.0,"Depreciation_1_Q1_USD":85000.0,"CommonStockSharesOutstanding_0_Q1_shares":75400000.0,"CommonStockSharesIssued_0_Q1_shares":75400000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":417881000.0,"AssetsCurrent_0_Q1_USD":672407000.0,"Assets_0_Q1_USD":688939000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":15307000.0,"AdditionalPaidInCapital_0_Q1_USD":1008275000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":1010000.0,"CommonStockValue_0_Q1_USD":7000.0,"RestrictedCash_0_Q1_USD":1016000.0,"NetIncomeLoss_1_Q1_USD":-168822000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":381593000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":1674000.0,"ShareBasedCompensation_1_Q1_USD":9294000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":69282000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":435000.0,"OperatingIncomeLoss_1_Q1_USD":-98786000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"AccruedLiabilitiesCurrent_0_Q1_USD":44930000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":73720.0,"StockholdersEquity_0_Q1_USD":258997000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-750295000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1972000.0,"ProfitLoss_1_Q1_USD":-168822000.0,"InterestPaidNet_1_Q1_USD":3829000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":334000.0,"Ticker":"APLS","CIK":"1492422","name":"APELLIS PHARMACEUTICALS, INC.","OfficialName":"Apellis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5553923312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200429"}]